EDWARDS LIFESCIENCES REPORTS SECOND QUARTER RESULTS

Go back to EDWARDS LIFESCIENCES REPORTS SECOND QUARTER RESULTS

Edwards Lifesciences (EW) Down on Earnings Miss as Hospital Staffing 'Remains Uncertain'

July 29, 2022 1:32 PM UTC

Edwards Lifesciences (NYSE: EW) shares have fallen over 6% Friday on the back of its earnings release.

The company reported after the close Thursday, missing earnings and revenue expectations.

Edwards Lifesciences reported earnings of $0.63, $0.01 worse than the analyst estimate of $0.64 on revenue of $1.37 billion, missing the consensus estimate of $1.4 billion.

The company said it experienced persistent disruption within the healthcare... More

Edwards Lifesciences (EW) Misses Q2 EPS by 1c, Q3 Revenue Guidance Misses

July 28, 2022 4:18 PM UTC

Edwards Lifesciences (NYSE: EW) reported Q2 EPS of $0.63, $0.01 worse than the analyst estimate of $0.64. Revenue for the quarter came in at $1.37 billion versus the consensus estimate of $1.4 billion.

GUIDANCE:

Edwards Lifesciences sees Q3 2022 EPS of $0.58-$0.66, versus the consensus of $0.65.... More